Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner R, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson M, Wirth A, Tsang R, Prica A, Major A, Smith S, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng A, Koenig J, Constine LS, Casulo C, Sakthivel G, Baron J, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh A, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel G, Brennan B, Penn A, Senchenko MA, Volchkov EV, Reeves M, Hoppe B, Terezakis S, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes E, Lee D, Doo NW, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar A, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS. Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses. Blood Adv. 2026 Aug 11; 10(15):5338-5347.

Kaddas HK, Ou JY, Alonzo T, Spector LG, Fallahazad N, Owens E, Kirchhoff AC, Green AL. Sociodemographic Factors Associated With Later Stage at Diagnosis of Pediatric Germ Cell Tumors: A Report From Children's Oncology Group Registries ACCRN07 and APEC14B1. Pediatr Blood Cancer. 2026 Oct; 73(10):e70562.

Mullen EA, Renfro LA, Ehrlich PF, Khanna G, Gratias EJ, Cost NG, Parsons LN, Grundy PE, Fernandez CV, Geller JI, Dome JS. Concordance Between Institutional and Central Pathology, Surgery, and Radiology Reviews on the Children's Oncology Group AREN03B2 Renal Tumor Biology and Classification Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70515.

Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA. Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial. JMIR Res Protoc. 2026 Jul 23; 15:e86281.

Rich BS, Fishbein JS, Purcell LN, Murphy JT, Castle SL, Ghanbari N, Zohrabian A, Lautz TB, Kacey W, Post G, Thangarajah H, West E, Roach JP, Corkum KS, Perry T, Piché N, Roy M, Stafman LL, Dixon SM, Glithero KJ, Pittman ME, Çeliker MY, Grant CN, Sharf T, Tracy ET, Wachsmuth LP, Rustad A, Newman EA, Williams K, Wunker CM, Glick RD, Dasgupta R, Wilson S, Vore E, Cromeens BP, Turk F, Shaffiey SA, Alkhoury F, Goyal J, Brown EG, Seemann NM, Wilson CA, Davidson J, Polites SF, Parrish MT, Cameron DB, Stetson A, Gold RM, Aldrink JH, Mansfield SA, Srivatsa S, Christison-Lagay E, Rehman SU, Fialkowski EA, Selesner L, Larsen A, Le HD, Tracy SA, Ahmed T, Dimmer A, Malek MM, Campwala I, Colangelo A, Rothstein DH, Nchinda NN, Mattei P, Jain S, Hwang R, Craig BT, Lal DR, Abrebese E, Rhee DS, Chidiac C, Peters M, Boehmer C, Billmire DF. Immature teratoma of the ovary in children and adolescents: A multi-institutional study of characteristics and management. Gynecol Oncol. 2026 Aug; 211:115-124.

Morganti S, Kim SE, Jin Q, Cha J, Zeigler JE, Newman AB, Kirkner GJ, Snow C, Zheng Y, Vincuilla J, Parker T, Buehler RM, Bychkovsky BL, Dibble KE, Sella T, Ruddy KJ, Rosenberg SM, Collins LC, Peppercorn J, Schapira L, Borges VF, Guzman-Arocho YD, Come SE, Warner E, Poorvu PD, Lambertini M, Curigliano G, Hughes ME, Mittendorf EA, King TA, Lin NU, Garber JE, Tayob N, Tolaney SM, Partridge AH, Lynce F. Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies. JNCI Cancer Spectr. 2026 Jul 07; 10(4).

Gorbatov ML, Arizpe A, David EA, Liu L, Cockburn M, Farias AJ. Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer. Cancer Causes Control. 2026 Jul 01; 37(7).

Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J, Burstein HJ, Chen N, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Jankowitz RC, Javid SH, Leitch AM, Lyons J, McCloskey S, McShane M, Patel SA, Rosenberger LH, Rugo HS, Santa-Maria CA, Schneider BP, Smith ML, Soliman H, Speers C, Telli ML, Wei M, Wisinski KB, Yellala A, Yeung KT, Young JS, Schonfeld R, Kumar R. Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2026 Jul; 24(7).

Zhang R, Chavana A, Shi Y, Zhou B, Ugarte V, Sun B, Guo B, Kazemifar S, Echeverria A, Ludwig M, Owrangi A. Dosimetric comparison of high dose rate interstitial brachytherapy and stereotactic body radiotherapy as alternative treatment methods for advanced-stage cervical cancer. Biomed Phys Eng Express. 2026 Jun 19; 12(3).

Tesch ME, Zheng Y, Guzman-Arocho YD, Collins LC, Heng YJ, Tayob N, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges V, Come SE, Snow C, Winer EP, Mittendorf EA, Partridge AH. Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer. Clin Cancer Res. 2026 Jun 01; 32(11):2268-2278.